19.11.2015
- A further regulatory milestone has been achieved by Merck KGaA and Pfizer after the US Food and Drug Administration (FDA) designated their potential skin cancer treatment avelumab...
19.11.2015
- Germany’s Merck KGaA has now completed its $17 billion acquisition of Sigma-Aldrich after clearing all anti-trust hurdles. With the integration of the US fine chemicals producer...
11.11.2015
- The European Commission has approved the sale of Sigma-Aldrich’s solvents and inorganics business in Europe to Honeywell, finally clearing the path for the US company’s acquisition...
23.10.2015
- US protein engineering company Codexis has completed wave 1 of the transfer of its proprietary CodeEvolver platform technology to compatriot drug maker Merck. Under the agreement...
21.10.2015
- Sigma-Aldrich will sell parts of its solvents and inorganics business in Europe to Honeywell, to enhance its chances of winning the European Commission’s approval for its $17...
14.10.2015
- As part of its "Fit for 2018" strategic transformation and growth program, Germany’s Merck KGaA has rebranded itself both in design and corporate structure. With the rebranding...
14.10.2015
- Stefan Oschmann has been named as new chief executive of Germany’s Merck KGaA, succeeding current CEO Karl-Ludwig Kley, who will retire following the German chemical and...
08.10.2015
- After previously receiving Orphan Drug status for avelumab, an investigational fully human anti-PD-L1 IgG1 monoclonal antibody to treat the rare and aggressive skin cancer Merkel...
